SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: recommendations from the French society for Immuno-Therapy of Cancer (FITC)

Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1

(2020) A. Bayle et al.   ANNALS OF ONCOLOGY

Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors

(2020) Melissa Bersanelli   Immunotherapy

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

(2020) Roch Houot et al.   EUROPEAN JOURNAL OF CANCER

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients

(2016) Elizabeth Frenzel et al.   AMERICAN JOURNAL OF INFECTION CONTROL